Polymorphisms in NRXN3, TFAP2B, MSRA, LYPLAL1, FTO and MC4R and their effect on visceral fat area in the Japanese population

Journal of Human Genetics

Volumn 55, Issue 11, 2010, Pages 738-742

  Hotta, Kikuko ^a   Nakamura, Michihiro ^a   Nakamura, Takahiro ^a,b   Matsuo, Tomoaki ^c   Nakata, Yoshio ^c   Kamohara, Seika ^d   Miyatake, Nobuyuki ^e   Kotani, Kazuaki ^f   Komatsu, Ryoya ^g   Itoh, Naoto ^h   Mineo, Ikuo ⁱ   Wada, Jun ^j   Yoneda, Masato ^k   Nakajima, Atsushi ^k   Funahashi, Tohru ^f   Miyazaki, Shigeru ^l   Tokunaga, Katsuto ^m   Kawamoto, Manabu ⁿ   Masuzaki, Hiroaki ^o   Ueno, Takato ^p   Hamaguchi, Kazuyuki ^q   Tanaka, Kiyoji ^c   Yamada, Kentaro ^p   Hanafusa, Toshiaki ^r   Oikawa, Shinichi ^s   Yoshimatsu, Hironobu ^q   Nakao, Kazuwa ^t   Sakata, Toshiie ^q   Matsuzawa, Yuji ^f   Nakamura, Yusuke ^u   Kamatani, Naoyuki ^a   more..

^a RIKEN   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d National Hospital Organization Kyoto Medical Center   (Japan)

^e Okayama Southern Institute of Health   (Japan)

^f OSAKA UNIVERSITY   (Japan)

^g Department of Cardiology   (Japan)

^h TOYONAKA MUNICIPAL HOSPITAL   (Japan)

ⁱ Otemae Hospital   (Japan)

^j OKAYAMA UNIVERSITY   (Japan)

^k YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^l Tokyo Postal Services Agency Hospital   (Japan)

^m Itami City Hospital   (Japan)

ⁿ TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^o UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^p KURUME UNIVERSITY   (Japan)

^q OITA UNIVERSITY   (Japan)

^r OSAKA MEDICAL COLLEGE   (Japan)

^s NIPPON MEDICAL SCHOOL   (Japan)

^t KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^u UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

fat mass and obesity associated (FTO); lysophospholipase like 1 (LYPLAL1); melanocortin 4 receptor (MC4R); methionine sulfoxide reductase A (MSRA); neurexin 3 (NRXN3); subcutaneous fat area; transcription factor AP 2 (TFAP2B); visceral fat area

Indexed keywords

LYSOPHOSPHOLIPASE; LYSOPHOSPHOLIPASE LIKE 1; MELANOCORTIN 4 RECEPTOR; METHIONINE SULFOXIDE REDUCTASE A; NEUREXIN; NEUREXIN 3; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DNA POLYMORPHISM; FAT MASS AND OBESITY ASSOCIATED GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRAABDOMINAL FAT; JAPANESE; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIPLE REGRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; METHIONINE SULFOXIDE REDUCTASES; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RECEPTOR, MELANOCORTIN, TYPE 4; TRANSCRIPTION FACTOR AP-2; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 78649508009     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.99     Document Type: Article

References (21)

1. Carr, D. B., Utzschneider, K. M., Hull, R. L., Kodama, K., Retzlaff, B. M., Brunzell, J. D. et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53, 2087-2094 (2004).
2. Pollex, R. L. & Hegele, R. A. Genetic determinants of the metabolic syndrome. Nat. Clin. Pract. Cardiovasc. Med. 3, 482-489 (2006).
3. Matsuzawa, Y. Therapy insight: adipokines in metabolic syndrome and related cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 3, 35-42 (2006).
4. Hotta, K., Funahashi, T., Bodkin, N. L., Ortmeyer, H. K., Arita, Y., Hansen, B.C. et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50, 1126-1133 (2001).
5. Arai, H., Yamamoto, A., Matsuzawa, Y., Saito, Y., Yamada, N., Oikawa, S. et al. Prevalence of metabolic syndrome in the general Japanese population in 2000. J. Atheroscler. Thromb. 13, 202-208 (2006).
6. Mastuzawa, Y. Metabolic syndrome-definition and diagnostic criteria in Japan. J. Atheroscler. Thromb. 12, 301 (2005).
7. Lindgren, C. M., Heid, I. M., Randall, J. C., Lamina, C., Steinthorsdottir, V., Qi, L. et al. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet. 5, e1000508 (2009).
8. Heard-Costa, N. L., Zillikens, M. C., Monda, K. L., Johansson, A., Harris, T. B., Fu, M. et al. NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet. 5, e1000539 (2009).
9. Yoshizumi, T., Nakamura, T., Yamane, M., Islam, A. H., Menju, M., Yamasaki, K. et al. Abdominal fat: standardized technique for measurement at CT. Radiology 211, 283-286 (1999).
10. Ohnishi, Y., Tanaka, T., Ozaki, K., Yamada, R., Suzuki, H. & Nakamura, Y. A high-throughput SNP typing system for genome-wide association studies. J. Hum. Genet. 46, 471-477 (2001).
11. Nielsen, D. M., Ehm, M. G. & Weir, B. S. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am. J. Hum. Genet. 63, 1531-1540 (1998).
12. Matsushita, Y., Nakagawa, T., Yamamoto, S., Takahashi, Y., Yokoyama, T., Noda, M. et al. Associations of visceral and subcutaneous fat areas with the prevalence of metabolic risk factor clustering in 6292 Japanese individuals: the Hitachi Health Study. Diabetes Care (in press).
13. Hotta, K., Nakata, Y., Matsuo, T., Kamohara, S., Kotani, K., Komatsu, R. et al. Variations in the FTO gene are associated with severe obesity in the Japanese. J Hum. Genet. 53, 546-553 (2008).
14. Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894 (2007).
15. Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345 (2007).
16. Scuteri, A., Sanna, S., Chen, W. M., Uda, M., Albai, G., Strait, J. et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 3, e115 (2007).
17. Gerken, T., Girard, C. A., Tung, Y. C., Webby, C. J., Saudek, V., Hewitson, K. S. et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318, 1469-1472 (2007).
18. Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A. et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168-176 (2007).
19. Jia, G., Yang, C. G., Yang, S., Jian, X., Yi, C., Zhou, Z. et al. Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett 582, 3313-3319 (2008).
20. Fischer, J., Koch, L., Emmerling, C., Vierkotten, J., Peters, T., Brüning, J. C. et al. Inactivation of the Fto gene protects from obesity. Nature 458, 894-898 (2009).
21. Church, C., Lee, S., Bagg, E. A., McTaggart, J. S., Deacon, R., Gerken, T. et al. A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genet. 5, e1000599 (2009).